Cystatin C Measurement Leads to Lower Metformin Dosage in Elderly Type 2 Diabetic Patients

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.13132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cystatin C Is an Important Biomarker for Cardiovascular Autonomic Dysfunction in Chinese Type 2 Diabetic Patients

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Cystatin C Level in Prediabetic and Diabetic Patients

Southern Clinics of Istanbul Eurasia
2017English

Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Cognitive Function and Brain Atrophy in Elderly Type 2 Diabetic Patients in Comparison With Non-Diabetic Elderly Subjects.

Japanese Journal of Geriatrics
GerontologyGeriatrics
2001English

Safe and Effective Prescription of Metformin in Elderly Patients With Type 2 Diabetes (T2DM)

Endocrinology&Metabolism International Journal
2018English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Basal Cortisol Levels in the Elderly and Middle-Aged Type 2 Diabetic Patients

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Metformin Associates With Lower on Colorectal Neoplastic Risk in African American Diabetic Patients

Integrative Cancer Science and Therapeutics
2016English

Cystatin C at Admission in the Intensive Care Unit Predicts Mortality Among Elderly Patients

ISRN Nephrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy